Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus.

Thalange N, Bereket A, Larsen J, Hiort LC, Peterkova V.

Pediatr Diabetes. 2011 Nov;12(7):632-41. doi: 10.1111/j.1399-5448.2010.00750.x. Epub 2011 Mar 21.

PMID:
21418455
[PubMed - indexed for MEDLINE]
2.

Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial.

Thalange N, Bereket A, Larsen J, Hiort LC, Peterkova V.

Diabet Med. 2013 Feb;30(2):216-25. doi: 10.1111/dme.12041.

PMID:
23094597
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.

Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, Landin-Olsson M, Hylleberg B, Lang H, Draeger E; Study to Evaluate the Administration of Detemir Insulin Efficacy, Safety and Suitability (STEADINESS) Study Group.

Diabetes Care. 2004 May;27(5):1081-7.

PMID:
15111525
[PubMed - indexed for MEDLINE]
4.
5.

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

Clin Ther. 2004 May;26(5):724-36.

PMID:
15220016
[PubMed - indexed for MEDLINE]
6.

Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study.

Sreenan S, Virkamäki A, Zhang K, Hansen JB; PREDICTIVE study group.

Int J Clin Pract. 2008 Dec;62(12):1971-80. doi: 10.1111/j.1742-1241.2008.01939.x. Erratum in: Int J Clin Pract. 2009 Jan;63(1):176-7:178-80.

PMID:
19166444
[PubMed - indexed for MEDLINE]
7.

Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes.

Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Brøndsted L, Jovanovic L, Damm P, McCance DR; Detemir in Pregnancy Study Group.

Diabetes Care. 2012 Oct;35(10):2012-7. Epub 2012 Jul 30.

PMID:
22851598
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA.

Diabetologia. 2004 Apr;47(4):622-9.

PMID:
15298338
[PubMed - indexed for MEDLINE]
9.

Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis.

Szypowska A, Golicki D, Groele L, Pańkowska E.

Pol Arch Med Wewn. 2011 Jul-Aug;121(7-8):237-46. Review.

PMID:
21878861
[PubMed - indexed for MEDLINE]
Free Article
10.

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

Raslová K, Bogoev M, Raz I, Leth G, Gall MA, Hâncu N.

Diabetes Res Clin Pract. 2004 Nov;66(2):193-201. Erratum in: Diabetes Res Clin Pract. 2006 Apr;72(1):112.

PMID:
15533587
[PubMed - indexed for MEDLINE]
11.

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J.

Diabet Med. 2007 Jan;24(1):27-34.

PMID:
17227321
[PubMed - indexed for MEDLINE]
12.

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.

Fulcher GR, Gilbert RE, Yue DK.

Intern Med J. 2005 Sep;35(9):536-42.

PMID:
16105155
[PubMed - indexed for MEDLINE]
13.
14.

Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs. NPH insulin from diagnosis: a retrospective study.

Salemyr J, Bang P, Örtqvist E.

Pediatr Diabetes. 2011 Aug;12(5):501-5. doi: 10.1111/j.1399-5448.2010.00723.x. Epub 2011 Mar 28.

PMID:
21443584
[PubMed - indexed for MEDLINE]
15.

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.

Kølendorf K, Ross GP, Pavlic-Renar I, Perriello G, Philotheou A, Jendle J, Gall MA, Heller SR.

Diabet Med. 2006 Jul;23(7):729-35.

PMID:
16842476
[PubMed - indexed for MEDLINE]
16.

The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes.

Standl E, Lang H, Roberts A.

Diabetes Technol Ther. 2004 Oct;6(5):579-88.

PMID:
15628811
[PubMed - indexed for MEDLINE]
17.

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.

Christiansen JS, Vaz JA, Metelko Z, Bogoev M, Dedov I.

Diabetes Obes Metab. 2003 Nov;5(6):446-54.

PMID:
14617231
[PubMed - indexed for MEDLINE]
18.

Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands.

Valentine WJ, Jendle J, Saraheimo M, Thorsteinsson B, Pollock RF, Lammert M.

Diabet Med. 2012 Mar;29(3):303-12. doi: 10.1111/j.1464-5491.2011.03461.x.

PMID:
21951030
[PubMed - indexed for MEDLINE]
19.

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.

Monami M, Marchionni N, Mannucci E.

Diabetes Obes Metab. 2009 Apr;11(4):372-8. doi: 10.1111/j.1463-1326.2008.00976.x. Review.

PMID:
19267715
[PubMed - indexed for MEDLINE]
20.

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.

Haak T, Tiengo A, Draeger E, Suntum M, Waldhäusl W.

Diabetes Obes Metab. 2005 Jan;7(1):56-64.

PMID:
15642076
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk